GlassScriptPhysician profile
Carl G Bevering
NPI 1215909171
$3,452.38
in general payments reported to CMS, 2019-2025
28 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $247 · 2021: $87.44 · 2022: $412 · 2023: $190 · 2024: $2,000 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187 · Travel and Lodging: $1,119 · Entertainment: $33.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.81 |
| Travel and Lodging | $1,119.08 |
| Entertainment | $33.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $1,723.70 | 2023-2025 | Optimesh Expandable Interbody Fusion System |
| Si-Bone, INC. | $298.47 | 2019-2023 | |
| Providence Medical Technology, INC. | $275.16 | 2020-2025 | |
| Medtronic, INC. | $142.01 | 2022-2024 | Intellis Adaptivestim |
| Portola Pharmaceuticals, LLC | $88.63 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $86.29 | 2019-2020 | |
| Cerapedics INC. | $83.36 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Csl Behring | $78.66 | 2024-2025 | Kcentra |
| Stryker Corporation | $68.91 | 2022-2024 | N/A, Airo |
| Azurity Pharmaceuticals, INC. | $64.73 | 2022-2023 | Gliadel |
| Alexion Pharmaceuticals, INC. | $59.05 | 2021-2022 | |
| Boston Scientific Corporation | $51.01 | 2023-2024 | Artisan, Wavewriter Alpha Prime 16 |
| Astrazeneca Pharmaceuticals LP | $48.14 | 2023-2024 | Andexxa |
| Orthofix Medical, INC. | $45.65 | 2022 | |
| Kerecis Limited | $45.62 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $36.10 | 2019-2024 | |
| Arkis Biosciences INC | $34.34 | 2019 | |
| Baxter Healthcare | $30.60 | 2022 | |
| Davol INC. | $28.18 | 2021-2022 | |
| Augmedics INC. | $25.43 | 2020-2021 | |
| Depuy Synthes Sales INC. | $23.04 | 2020 | |
| Integra Lifesciences Corporation | $19.09 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Vertex Pharmaceuticals Incorporated | $17.51 | 2025 | |
| Smith+Nephew, INC. | $17.25 | 2019 | |
| Chiesi USA, INC. | $16.96 | 2019 | |
| Trevena, INC. | $16.18 | 2021 | |
| 4web, INC. | $14.27 | 2022 | |
| Intrinsic Therapeutics | $14.04 | 2023 | Barricaid Acd (Annular Closure Device) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Bevering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.